National Clinical Research Center for Cancer in China signs agreement to use AI for breast cancer diagnosis
The National Clinical Research Center for Cancer (NCRCC) in China has signed a deal with the Institute of Computing Technology under the Chinese Academy of Sciences (CAS) to use artificial intelligence (AI) in medical imaging. The Tianjin Medical University Cancer Institute and Hospital was appointed as the NCRCC by the Ministry of Science and Technology of The People's Republic of China (PRC) in 2013.
No comments:
Post a Comment